Edgewise Therapeutics, Inc.
EWTX • NASDAQ
Edgewise Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Kevin Koch, with a market cap of $3.5B.
Market Cap$3.5B
Employees92.0
CEOKevin Koch
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 1 weekBefore Market Open · Q1 2026
Financials
Edgewise Therapeutics, Inc. FAQ
Common questions about Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026 before market open.
Edgewise Therapeutics, Inc. has approximately 92 employees.